Identifying multiple knee pain trajectories and the prediction of opioid and NSAID medication used: A latent class growth approach. Issue 2 (25th October 2021)

• Record Type: Journal Article
• Authors: Haybatollahi, Sayyed M.; James, Richard J. E.; Fernandes, Gwen; Valdes, Ana; Doherty, Michael; Zhang, Weiya; Walsh, David A.; Ferguson, Eamonn
• Is Part Of: Pain practice. Volume 22:Issue 2(2022)
• Page Start: 210
• Page End: 221
• Publication Date: 2021-10-25
• Subjects: knee pain -- knee pain trajectories -- latent class growth analysis -- osteoarthritis -- pain progression; Pain -- Treatment -- Periodicals; 616.0472
• DOI: 10.1111/papr.13082
• Languages: English
• ISSNs: 1530-7085

Abstract

Abstract: Background: Knee pain is a major source of distress and disability, with pain progression highly variable between individuals. Previous studies defining pain trajectories have all used a single measure of pain, and these differ across studies. Different measures reflect diverse pain mechanisms. To ascertain the clinical utility of pain trajectories, we explored associations between opioid and non‐steroidal anti‐inflammatory drug (NSAID) use. Methods: We model pain trajectories using two measures—Intermittent and Constant Osteoarthritis Pain (ICOAP) and the painDETECT, in 2141 participants, across 3 waves (the baseline, 1‐ and 3‐year assessments) of the Knee Pain In the Community (KPIC) cohort. Results: Latent class growth analysis identified six trajectories using ICOAP subscales (High‐Stable, Low‐Stable, Moderate Worsening, Moderate Recovering, Worsening, and Recovering) and four trajectories using painDETECT (High‐stable, Low‐stable, Moderate Worsening, and Moderate Recovering). There was a high degree of correspondence between people assigned to pain trajectories between ICOAP intermittent and constant subscales, but less so using painDETECT. Opioid use was associated with ICOAP trajectories only (e.g., High‐Stable and Worsening intermittent ICOAP trajectories) and in women. Conclusion: Different measures of pain produce different patterns of pain progression and these are differentially related to medication use. Opioid use is linked to trajectories of pain based on the impact of pain on behavior and not pain symptoms. Thus, managing pain's behavioral impact is more central to understanding opioid use than managing pain symptoms. These findings support more in‐depth questioning about the type of pain and its progression in clinical practice.